NewsBenzingaJefferies Initiates Coverage On Twist Bioscience with Hold Rating, Announces Price Target of $150 Jefferies Initiates Coverage On Twist Bioscience with Hold Rating, Announces Price Target of $150 Benzinga 2026.10.08 12:52 (GMT+0) Open on Benzinga Other news BlackRock’s Larry Fink Warns AI Data Center Halt Could Tip US Into Recession Nike, Moderna, Walmart Get a Lift as Traders Flee AI Stocks Why Is Cisco Stock Falling on Thursday? Google Quantum AI Achieves 40-Fold Error Reduction In Magic State Cultivation, Advancing Practical Quantum Computing Google's $4 Billion Fuel-Cell Project Puts Bloom Energy's AI Power Backlog to the Test Why Is Arcutis Biotherapeutics Stock Surging Thursday?
Google Quantum AI Achieves 40-Fold Error Reduction In Magic State Cultivation, Advancing Practical Quantum Computing
